POST Online Media Lite Edition


Arcadia Bio appoints two to board

Staff Writer |
Davis, Ca., USA - June 14, 2017, Davis, Ca., USA - Arcadia Biosciences, an agricultural technology company, announced that Eric J. Rey and Gregory D. Waller have joined its board of directors.

Eric J. Rey is one of the founders of Arcadia Biosciences and served as president and CEO, as well as a director, until 2016.

Prior to founding Arcadia, Mr. Rey was a partner with Rockridge Group, a management consulting firm for early-stage companies developing genomic, biopharmaceutical, nutraceutical, crop protection, animal nutrition and health, alternative crop and industrial products.

Mr. Rey previously served as vice president of operations with Calgene, Inc., including two years with Monsanto Company following its acquisition of Calgene.

Mr. Rey holds a B.S. in plant science from the University of California, Davis.

He currently serves as a director for Phytelligence, Inc. and Texas Crop Science, LLC.

Gregory D. Waller is the former chief financial officer of Ulthera Corporation, a privately-held company providing ultrasound technology for aesthetic and medical applications, which was acquired by Merz North America in 2014.

Previously, Mr. Waller was CFO of Universal Building Products and Sybron Dental Specialties, Inc., and vice president and treasurer of Kerr, Ormco Corporation, and Metrex.

Mr. Waller has extensive experience serving on the boards of public companies and currently serves as a director for Sunshine Heart and Endologix Corporation.


What to read next

Arcadia Bio appoints Matthew Plavan as CFO
Arcadia Bio names new chief executive
Protagonist Therapeutics names Thomas P. O'Neil CFO